OrthoPediatrics (NASDAQ: KIDS) is one of 19 public companies in the “Medical Devices & Implants” industry, but how does it weigh in compared to its peers? We will compare OrthoPediatrics to related businesses based on the strength of its profitability, valuation, institutional ownership, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations and price targets for OrthoPediatrics and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics 0 0 4 0 3.00
OrthoPediatrics Competitors 109 727 1025 10 2.50

OrthoPediatrics presently has a consensus price target of $23.67, indicating a potential upside of 20.26%. As a group, “Medical Devices & Implants” companies have a potential upside of 38.07%. Given OrthoPediatrics’ peers higher possible upside, analysts plainly believe OrthoPediatrics has less favorable growth aspects than its peers.

Profitability

This table compares OrthoPediatrics and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OrthoPediatrics N/A N/A N/A
OrthoPediatrics Competitors -101.23% -92.70% -30.32%

Institutional and Insider Ownership

54.9% of shares of all “Medical Devices & Implants” companies are held by institutional investors. 11.9% of shares of all “Medical Devices & Implants” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares OrthoPediatrics and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
OrthoPediatrics N/A N/A 20.50
OrthoPediatrics Competitors $1.67 billion $207.58 million 55.89

OrthoPediatrics’ peers have higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

About OrthoPediatrics

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include RESPONSE Spinal Deformity System, PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table. It markets over 20 surgical systems that serve approximately three categories within pediatric orthopedic market, including trauma and deformity, complex spine and anterior cruciate ligament reconstruct

Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with MarketBeat.com's FREE daily email newsletter.